Literature DB >> 6425220

Mechanism of impaired iron release by the reticuloendothelial system during the hypoferremic phase of experimental Neisseria meningitidis infection in mice.

E D Letendre, B E Holbein.   

Abstract

Hypoferremia, the reduction of plasma transferrin iron levels during infection, has been shown to control Neisseria meningitidis infection in mice. The exact nature of the mechanism that regulates this response has been obscure. We have previously shown that hypoferremia does not result from an accelerated removal of iron from the plasma transferrin pool. In this study, we have examined the processing of iron by the reticuloendothelial system during infection. Normal and hypoferremic meningococcus-infected mice were injected with 59Fe-labeled erythrocytes. Kinetics of uptake and redistribution of the label indicated that during the hypoferremic phase of the infection, reticuloendothelial system-processed iron was not returned to the plasma transferrin pool. Fractionation of hepatic cellular compartments showed that this impaired release of iron resulted from a preferential incorporation of heme-derived iron into the intracellular ferritin pool during the hypoferremic phase of the infection. These findings indicate that this withholding of iron within the intracellular pool leads to hypoferremia and therefore denies the extracellular pathogen its essential iron.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425220      PMCID: PMC263520          DOI: 10.1128/iai.44.2.320-325.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  The role of the reticulo-endothelial cell in iron metabolism.

Authors:  W D NOYES; T H BOTHWELL; C A FINCH
Journal:  Br J Haematol       Date:  1960-01       Impact factor: 6.998

2.  The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production.

Authors:  E J FREIREICH; A MILLER; C P EMERSON; J F ROSS
Journal:  Blood       Date:  1957-11       Impact factor: 22.113

3.  Studies of the anemia and iron metabolism in cancer.

Authors:  R B CHODOS; C P EMERSON; A MILLER; J F ROSS
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

Review 4.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

Review 5.  Storage iron regulation.

Authors:  C Hershko
Journal:  Prog Hematol       Date:  1977

6.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

7.  Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Iron-controlled infection with Neisseria meningitidis in mice.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 9.  Iron metabolism in reticuloendothelial cells.

Authors:  A Deiss
Journal:  Semin Hematol       Date:  1983-04       Impact factor: 3.851

10.  The involvement of lactoferrin in the hyposideremia of acute inflammation.

Authors:  J L Van Snick; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.

Authors:  Jyoti Upadhyay; Nidhi Tiwari; Mohd N Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-07

Review 2.  Hyperferritinemia and inflammation.

Authors:  Kate F Kernan; Joseph A Carcillo
Journal:  Int Immunol       Date:  2017-11-01       Impact factor: 4.823

3.  Ceruloplasmin and regulation of transferrin iron during Neisseria meningitidis infection in mice.

Authors:  E D Letendre; B E Holbein
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

4.  Inflammation triggers hypoferremia and de novo synthesis of serum transferrin and ceruloplasmin in mice.

Authors:  D L Beaumier; M A Caldwell; B E Holbein
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 5.  Iron metabolism during infection and neoplasia.

Authors:  E D Letendre
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Bactericidal activity of M14659 enhanced in low-iron environments.

Authors:  H Mochizuki; H Yamada; Y Oikawa; K Murakami; J Ishiguro; H Kosuzume; N Aizawa; E Mochida
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

7.  The meningococcal ABC-Type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice.

Authors:  Roberta Colicchio; Susanna Ricci; Florentia Lamberti; Caterina Pagliarulo; Chiara Pagliuca; Velia Braione; Tiziana Braccini; Adelfia Talà; Donatella Montanaro; Sergio Tripodi; Marcella Cintorino; Giancarlo Troncone; Cecilia Bucci; Gianni Pozzi; Carmelo B Bruni; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

8.  The macrophage scavenger receptor A is host-protective in experimental meningococcal septicaemia.

Authors:  Annette Plüddemann; J Claire Hoe; Katherine Makepeace; E Richard Moxon; Siamon Gordon
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

Review 9.  Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.

Authors:  Bruce E Holbein; M Trisha C Ang; David S Allan; Wangxue Chen; Christian Lehmann
Journal:  Environ Chem Lett       Date:  2021-04-23       Impact factor: 9.027

10.  Biochemical predictors for Sars-Cov-2 severity.

Authors:  Ezhil Gurusamy; S Mahalakshmi; Gurumoorthy Kaarthikeyan; K Ramadevi; Parkavi Arumugam; M S Gayathri
Journal:  Bioinformation       Date:  2021-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.